Effect of increased warfarin use on warfarin-related cerebral hemorrhage: A longitudinal population-based study

Stroke

Volumn 42, Issue 9, 2011, Pages 2431-2435

  Huhtakangas, Juha ^a   Tetri, Sami ^a   Juvela, Seppo ^b   Saloheimo, Pertti ^a   Bode, Michaela K ^a   Hillbom, Matti ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

epidemiology; intracerebral hemorrhage; outcome; warfarin

Indexed keywords

WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; DRUG FATALITY; DRUG USE; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; STROKE; SURVIVAL RATE; THROMBOEMBOLISM; TREND STUDY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; FEMALE; FINLAND; HUMANS; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; WARFARIN;

EID: 80052401993     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.615260     Document Type: Article

References (23)

1. Quintero-González JA. Fifty years of clinical use of warfarin. Invest Clin. 2010;51:269-287.
2. Virjo I, Mäkelä K, Aho J, Kalliola P, Kurunmäki H, Uusitalo L, et al. Who receives anticoagulant treatment with warfarin and why? A population-based study in Finland. Scand J Prim Health Care. 2010;28:237-241.
3. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke. 1995;26:1471-1477.
4. Lakshminarayan K, Anderson DC, Herzog CA, Qureshi AI. Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States. Neurologist. 2008;14:143-150.
5. Kucher N, Castellanos LR, Quiroz R, Koo S, Fanikos J, Goldhaber SZ. Time trends in warfarin-associated hemorrhage. Am J Cardiol. 2004;94: 403-406.
6. Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68:116-121.
7. Meretoja A, Roine RO, Kaste M, Linna M, Juntunen M, Erilä T, et al. Stroke monitoring on a national level. PERFECT Stroke, a comprehensive, registry-linkage stroke database in Finland. Stroke. 2010;41: 2239-2246.
8. Whitworth JA, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992.
9. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81-84.
10. Saloheimo P, Juvela S, Riutta A, Pyhtinen J, Hillbom M. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. Thromb Res. 2005;115:367-373.
11. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987-993.
12. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27:1304-1305.
13. Sheth KN, Cushing TA, Wendell L, Lev MH, Romero JM, Schwab K, et al. Comparison of hematoma shape and volume estimates in warfarin versus non-warfarin-related intracerebral hemorrhage. Neurocrit Care. 2010;12:30-34.
14. Lawrentschuk N, Kariappa S, Kaye AH. Spontaneous intracerebral haemorrhages-warfarin as a risk factor. J Clin Neurosci. 2003;10:550-552.
15. Jeffree RL, Gordon DH, Sivasubramaniam R, Chapman A. Warfarin related intracranial haemorrhage: a case-controlled study of anticoagulation monitoring prior to spontaneous subdural or intracerebral haemorrhage. J Clin Neurosci. 2009;16:882-885.
16. Cordonnier C, Rutgers MP, Dumont F, Pasquini M, Lejeune J-P, Garrigue D, et al. Intra-cerebral haemorrhages: are there any differences in baseline characteristics and intra-hospital mortality between hospital-and population-based registries? J Neurol. 2009;256:198-202.
17. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol. 1997;42:857-865.
18. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004;164:880-884.
19. Flaherty ML, Tao H, Haverbusch M, Sekar P, Kleindorfer D, Kissela B, et al. Warfarin use leads to larger intracerebral hematomas. Neurology. 2008;71:1084-1089.
20. Gasse C, Hollowell J, Meier CR, Haefeli WE. Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin. Thromb Haemost. 2005; 94:537-543.
21. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059-1064.
22. Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy. Current practices and unresolved questions. Stroke. 2006;37:256-262.
23. Aguilar MI, Hart RG, Kase CS, Freeman WD, Hoeben MBJ, Garcia RC, et al. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc. 2007;82:82-92.